111 related articles for article (PubMed ID: 8514634)
1. Conformation studies on and assessment by spectral analysis of the protein-chromophore interaction of the macromolecular antitumor antibiotic C-1027.
Otani T
J Antibiot (Tokyo); 1993 May; 46(5):791-802. PubMed ID: 8514634
[TBL] [Abstract][Full Text] [Related]
2. Specific interaction between a novel enediyne chromophore and apoprotein in macromolecular antitumor antibiotic C-1027.
Matsumoto T; Okuno Y; Sugiura Y
Biochem Biophys Res Commun; 1993 Sep; 195(2):659-66. PubMed ID: 8373405
[TBL] [Abstract][Full Text] [Related]
3. Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore.
Tanaka T; Fukuda-Ishisaka S; Hirama M; Otani T
J Mol Biol; 2001 May; 309(1):267-83. PubMed ID: 11491295
[TBL] [Abstract][Full Text] [Related]
4. Computer modeling analysis for enediyne chromophore-apoprotein complex of macromolecular antitumor antibiotic C-1027.
Okuno Y; Otsuka M; Sugiura Y
J Med Chem; 1994 Jul; 37(15):2266-73. PubMed ID: 8057275
[TBL] [Abstract][Full Text] [Related]
5. Characterization of secondary structure of neocarzinostatin apoprotein.
Saito K; Sato Y; Edo K; Akiyama-Murai Y; Koide Y; Ishida N; Mizugaki M
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3078-82. PubMed ID: 2534360
[TBL] [Abstract][Full Text] [Related]
6. Conformations of protein moieties and chromophore-protein interactions in the antitumor antibiotics, macromomycin and auromomycin, characterized by IR and CD spectral analysis.
Miwa N
J Antibiot (Tokyo); 1982 Nov; 35(11):1553-60. PubMed ID: 7161194
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between the molecular composition of C1027, a new macromolecular antibiotic with enediyne chromophore, and its antitumor activity].
Shao RG; Zhen YS
Yao Xue Xue Bao; 1995; 30(5):336-42. PubMed ID: 7660803
[TBL] [Abstract][Full Text] [Related]
8. Aminopeptidase activity of an antitumor antibiotic, C-1027.
Sakata N; Tsuchiya KS; Moriya Y; Hayashi H; Hori M; Otani T; Nagai M; Aoyagi T
J Antibiot (Tokyo); 1992 Jan; 45(1):113-7. PubMed ID: 1548181
[TBL] [Abstract][Full Text] [Related]
9. Cloning and nucleotide sequencing of the antitumor antibiotic C-1027 apoprotein gene.
Sakata N; Ikeno S; Hori M; Hamada M; Otani T
Biosci Biotechnol Biochem; 1992 Oct; 56(10):1592-5. PubMed ID: 1369059
[TBL] [Abstract][Full Text] [Related]
10. Disruption of cagA, the apoprotein gene of chromoprotein antibiotic C-1027, eliminates holo-antibiotic production, but not the cytotoxic chromophore.
Cui Z; Wang L; Wang S; Li G; Hong B
FEMS Microbiol Lett; 2009 Nov; 301(1):57-68. PubMed ID: 19845765
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor activity of new antitumor antibiotic C1027 and its monoclonal antibody assembled conjugate].
Shao RG; Zhen YS
Yao Xue Xue Bao; 1992; 27(7):486-91. PubMed ID: 1442079
[TBL] [Abstract][Full Text] [Related]
12. Sequential 1H, 13C, and 15N NMR assignments and solution conformation of apokedarcidin.
Constantine KL; Colson KL; Wittekind M; Friedrichs MS; Zein N; Tuttle J; Langley DR; Leet JE; Schroeder DR; Lam KS
Biochemistry; 1994 Sep; 33(38):11438-52. PubMed ID: 7918358
[TBL] [Abstract][Full Text] [Related]
13. Antitumor enediyne chromoprotein C-1027: mechanistic investigation of the chromophore-mediated self-decomposition pathway.
Inoue M; Usuki T; Lee N; Hirama M; Tanaka T; Hosoi F; Ohie S; Otani T
J Am Chem Soc; 2006 Jun; 128(24):7896-903. PubMed ID: 16771503
[TBL] [Abstract][Full Text] [Related]
14. An antitumor polypeptide antibiotic neocarzinostatin: the mode of apo-protein--chromophore interaction.
Edo K; Saito K; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
J Antibiot (Tokyo); 1988 Apr; 41(4):554-62. PubMed ID: 2967272
[TBL] [Abstract][Full Text] [Related]
15. Rational design of a supra C-1027: kinetically stabilized analogue of the antitumor enediyne chromoprotein.
Usuki T; Inoue M; Hirama M; Tanaka T
J Am Chem Soc; 2004 Mar; 126(10):3022-3. PubMed ID: 15012111
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of a novel chromoprotein derived from apo-neocarzinostatin and a synthetic chromophore.
Urbaniak MD; Muskett FW; Finucane MD; Caddick S; Woolfson DN
Biochemistry; 2002 Oct; 41(39):11731-9. PubMed ID: 12269815
[TBL] [Abstract][Full Text] [Related]
17. Crystallization and preliminary X-ray crystallographic studies of a macromolecular antitumour antibiotic, C1027.
Chen Y; Shao R; Bartlam M; Li J; Jin L; Gao Y; Liu Y; Tang H; Zhen Y; Rao Z
Acta Crystallogr D Biol Crystallogr; 2002 Jan; 58(Pt 1):173-5. PubMed ID: 11752804
[TBL] [Abstract][Full Text] [Related]
18. Kedarcidin, a new chromoprotein antitumor antibiotic. II. Isolation, purification and physico-chemical properties.
Hofstead SJ; Matson JA; Malacko AR; Marquardt H
J Antibiot (Tokyo); 1992 Aug; 45(8):1250-4. PubMed ID: 1399845
[TBL] [Abstract][Full Text] [Related]
19. [A monoclonal antibody directed against an enediyne antitumor antibiotic and its preliminary application].
Zhou CS; Xu LN; Jiang M; Zhen YS
Yao Xue Xue Bao; 1997; 32(1):28-32. PubMed ID: 11243214
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of the beta-amino acid moiety of the enediyne antitumor antibiotic C-1027 featuring beta-amino acyl-S-carrier protein intermediates.
Van Lanen SG; Dorrestein PC; Christenson SD; Liu W; Ju J; Kelleher NL; Shen B
J Am Chem Soc; 2005 Aug; 127(33):11594-5. PubMed ID: 16104723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
